复合疝气修补片市场按材料类型、方法、最终用户和应用划分－全球预测，2026-2032年

预计到 2025 年，复合疝气修补片市场价值将达到 11.4 亿美元，到 2026 年将成长至 11.9 亿美元，到 2032 年将达到 17.2 亿美元，年复合成长率为 6.11%。

关键市场统计数据
基准年 2025	11.4亿美元
预计年份：2026年	11.9亿美元
预测年份 2032	17.2亿美元
复合年增长率 (%)	6.11%

本文概述了复合疝气修补片的临床原理、监管趋势以及影响其应用路径和产品开发的相关人员优先事项。

复合疝气修补片已成为现代疝气修补术中不可或缺的工具，它结合了基质和屏障技术，旨在平衡组织完整性和降低粘连风险。本文概述了其临床原理、核心产品特性以及相关人员的考量，这些因素共同决定了当前的应用趋势，并为更深入的分析奠定了基础。临床医生主要根据生物相容性、操作特性、固定要求和长期患者疗效来评估复合结构，这些结构影响采购和产品开发决策。

手术技术偏好、材料创新和采购压力的重大变化正在重新定义产品设计和应用趋势。

近年来，复合疝气修补片的研发、应用和报销方式发生了许多变化，了解这些变化对于策略规划至关重要。首先，微创和日间手术流程的兴起，使得针对腹腔镜操作性、快速部署和牢固固定而优化的网片变得尤为重要，进而影响了产品设计选择和培训投入。因此，製造商优先考虑低轮廓结构和输送系统，以缩短手术时间并简化无需缝合和钉合的固定方式。

关税主导的供应链重组、采购多元化和采购审查力度增加对成本管理和商业性合作的影响（2025年）

2025年美国关税政策对复合疝气修补片相关人员的供应链、筹资策略和价格优化工作产生了重大影响。为了应对关税带来的成本压力，製造商和经销商重新评估了其采购策略，优先考虑近岸外包和供应商多元化，以降低对单一供应商的依赖风险。这些调整需要营运投资和重新谈判供应商合同，导致过渡期内出现短期库存和物流方面的挑战，进而影响前置作业时间和采购计画。

基于全面细分的观点能够揭示临床、材料、流程和通路等方面的具体驱动因素，从而释放客製化的商业化策略。

透过结构化細項分析复合疝气修补术市场格局，可以深入了解临床需求与商业性机会的交会点。在考虑最终使用者时，门诊手术中心和医院之间存在着截然不同的需求路径。独立门诊中心和医院附属门诊中心优先考虑的是手术量、器械易用性和门诊病人康復指标，而私立和公立医院则优先考虑的是手术覆盖范围广、长期疗效数据以及与医院处方集相符的合约条款。这种差异对销售策略、培训计画和库存模式都具有重要意义。

深入的区域分析，重点关注全球医疗保健市场的监管差异、报销复杂性和客製化商业化方法。

区域趋势将对复合疝气修补片的推广路径、监管反应和商业性实施产生重大影响。根据当地实际情况调整产品设计和市场推广策略是製定有效策略的关键。在美洲，公立和私立医疗机构的医疗保健体系差异显着，先进的外科手术主要集中在大型医疗中心。这使得实证医学研究和支持微创手术的外科医生培训计画成为优先事项。该地区的医保报销机制和医院采购委员会强调併发症和再入院率的显着降低。

策略竞争格局分析表明，材料创新、证据产生和供应链韧性如何驱动差异化和商业性优势。

在复合疝气修补片领域，各公司之间的竞争体现出不同的策略策略，领导企业透过研发投入、製造地和临床证据累积来脱颖而出。专注于材料创新的公司致力于改进涂层技术和聚合物配方，以期在防止粘连和促进组织整合方面获得更显着的临床优势；而强调系统级解决方案的公司则将输送装置、固定辅助工具和外科医生培训相结合，构建能够缩短手术时间并降低併发症风险的价值提案。

为製造商和医疗服务提供者提供切实可行、影响深远的策略行动，以加速临床应用、降低价值链风险并展现手术价值。

产业领导者可以采取多项切实可行的措施，贯穿复合疝气修补片价值链，以巩固市场地位、推动产品普及并管控风险。首先，将产品设计与手术流程相匹配——尤其是在优化腹腔镜输送系统的同时，保持对开放性手术技术的通用性——可以减轻外科医生的负担并扩大适用范围。投资外科医生培训和指导，可以帮助製造商缩短学习曲线，并在不同的临床环境中验证治疗效果的一致性。

该研究透过结合专家访谈、临床文献综合和供应链分析的稳健的多方法研究设计，检验了其研究结果和建议。

本执行摘要的研究采用了多方法研究模式，整合了定性和定量数据，以确保研究结果的可靠性、检验和与相关人员的相关性。主要研究包括对各类相关人员进行结构化访谈，这些利害关係人包括精通腹腔镜和开放性手术的外科医生、医院采购人员、分销公司高阶主管和监管专家。这些访谈深入了解了手术技术偏好、证据期望和分销管道机制。

整合临床、技术和商业性的必要因素，以支持创新、证据和营运执行的策略协调，从而实现持续应用。

本执行摘要了目前影响复合疝气修补片市场的临床需求、材料创新、监管趋势和商业性因素之间的相互作用。关键主题包括：微创治疗的持续发展、兼具减少沾黏和组织整合功能的先进复合材料和涂层的涌现，以及在政策主导的成本压力下对稳健供应链的需求。这些趋势正在影响製造商和分销商的产品设计、证据优先顺序和市场推广模式。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 市场进入策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 复合疝气修补片市场（依材料类型划分）

• ePTFE复合材料
• 聚丙烯复合材料

9. 复合疝气修补片市场（治疗方法划分）

• 腹腔镜修补术
  • TAPP
  • TEP
• 开放性手术

第十章 依最终用户分類的复合疝气修补片市场

• 门诊手术中心
• 医院
  • 私立医院
  • 公立医院

第十一章 复合疝气修补片市场（按应用领域划分）

• 切口疝
  • 第一切口疝
  • 復发性切口疝
• 腹股沟疝气
• 腹壁疝
  • 上腹部
  • 脐部

第十二章 复合疝气修补片市场（按地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章 复合疝气修补片市场（依组别划分）

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国复合疝气修补片市场

• 我们
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

15. 美国复合疝气修补片市场

第十六章：中国复合疝气修补片市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Aesculap AG
• Atrium Medical Corporation
• B. Braun Melsungen AG
• Baxter International Inc.
• Baxter International Inc.
• Becton, Dickinson and Company
• CR Bard, Inc.
• Coloplast A/S
• CONMED Corporation
• Cook Medical Incorporated
• Cousin Biotech
• Dipromed SRL
• FEG Textiltechnik mbH
• Getinge AB
• Integra LifeSciences Holdings Corporation
• Johnson & Johnson
• Lifecell Corporation
• Lohmann & Rauscher GmbH & Co. KG
• Medtronic plc
• Smith & Nephew plc
• Tela Bio, Inc.
• Teleflex Incorporated
• Tepha, Inc.
• WL Gore & Associates, Inc.

The Composite Hernia Patch Market was valued at USD 1.14 billion in 2025 and is projected to grow to USD 1.19 billion in 2026, with a CAGR of 6.11%, reaching USD 1.72 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 1.14 billion
Estimated Year [2026]	USD 1.19 billion
Forecast Year [2032]	USD 1.72 billion
CAGR (%)	6.11%

Foundational overview of composite hernia patch clinical rationale, regulatory signals, and stakeholder priorities that shape adoption pathways and product development

Composite hernia patches have become pivotal tools in modern hernia repair, combining engineered substrates and barrier technologies to balance tissue integration with reduced adhesion risk. This introduction frames the clinical rationale, core product attributes, and stakeholder considerations that define current adoption dynamics, while setting the tone for deeper analysis. Clinicians evaluate composite constructs primarily on biocompatibility, handling characteristics, fixation requirements, and long-term patient outcomes, and these clinical priorities shape procurement and product development decisions.

From a commercial perspective, payers and providers increasingly demand evidence of comparative performance, procedural efficiency, and cost-effectiveness. Concurrently, regulatory authorities emphasize safety data and post-market surveillance, prompting manufacturers to invest in real-world evidence and iterative design improvements. Patient demographics and rising demand for outpatient procedures further influence packaging and sterilization formats, as well as surgeon training programs that ease the transition between open and minimally invasive techniques.

Taken together, the clinical, regulatory, and operational drivers establish a foundation for strategic positioning. As stakeholders seek devices that reconcile ease of use with consistent clinical outcomes, the composite hernia patch occupies a critical intersection of material science and surgical workflow optimization. This introduction prepares readers for a structured examination of market dynamics, segmentation nuances, and strategic implications that follow.

Critical evolution in surgical technique preferences, material innovations, and procurement pressures that are redefining product design and adoption dynamics

Over recent years, multiple transformative shifts have redefined how composite hernia patches are developed, adopted, and reimbursed, and understanding these shifts is essential for strategic planning. First, the move toward minimally invasive procedures and same-day surgical workflows has elevated the importance of meshes optimized for laparoscopic handling, rapid deployment, and secure fixation, thereby influencing product design choices and training investments. As a result, manufacturers are prioritizing low-profile constructs and delivery systems that reduce operative time and simplify suturing or tack-free fixation.

Second, material science advances-particularly in composite substrates and anti-adhesive coatings-have improved the balance between tissue integration on the visceral side and adhesion prevention on the peritoneal interface. This technological progress is accompanied by a heightened focus on biocompatible polymers and surface modifications that mitigate chronic inflammation and seroma formation. Consequently, differentiation increasingly rests on demonstrable clinical endpoints rather than labeling alone.

Third, supply chain resilience and regulatory vigilance have gained prominence, prompting diversified sourcing and enhanced quality controls. Moreover, payer scrutiny and value-based procurement models are driving demands for longitudinal evidence and bundled care paradigms that reward reduced complications and readmissions. Together, these shifts are reshaping commercial strategies, clinical adoption patterns, and R&D priorities across the ecosystem.

How tariff-driven supply chain reconfiguration, sourcing diversification, and procurement scrutiny reshaped cost management and commercial engagement in 2025

The policy environment introduced by the United States tariffs in 2025 has generated meaningful implications across supply chains, sourcing strategies, and price optimization efforts for composite hernia patch stakeholders. In response to tariff-driven cost pressures, manufacturers and distributors reassessed sourcing, favoring nearshoring and diversified supplier portfolios to mitigate single-origin exposure. These adjustments required operational investments and renegotiation of supplier contracts, and the transition periods produced short-term inventory and logistics challenges that affected lead times and procurement planning.

Consequently, health systems and ambulatory surgical centers adopted more rigorous procurement frameworks to manage total landed costs, including duties, freight, and inventory holding. This shift led some buyers to prioritize suppliers with vertically integrated manufacturing or local production capabilities to stabilize supply and reduce tariff vulnerability. At the same time, the additional cost pressure accelerated cost-containment discussions with clinical teams and devices committees, emphasizing the need to demonstrate procedure-level value and complication reduction.

In parallel, tariff-induced pricing volatility intensified the focus on distributor relationships versus direct sales channels, with organizations reassessing contractual terms to preserve margin and service levels. Taken together, the tariff environment catalyzed strategic realignment across sourcing, pricing, and commercial engagement models that will influence procurement decisions and competitive positioning.

Comprehensive segmentation-driven perspective revealing clinical, material, procedural, and channel-specific drivers that unlock tailored commercialization strategies

Analyzing the composite hernia patch landscape through structured segmentation reveals actionable insights about where clinical demand converges with commercial opportunity. When end users are considered, ambulatory surgical centers and hospitals present distinct pathways; ambulatory centers, both freestanding and hospital-affiliated, emphasize throughput, device ease of use, and outpatient recovery metrics, while private and public hospitals prioritize broad procedural coverage, long-term outcome data, and contract terms that align with institutional formularies. This contrast informs sales strategies, training programs, and inventory models.

Approach-based segmentation further distinguishes product requirements, as laparoscopic repair modalities such as TAPP and TEP necessitate low-profile profiles and delivery systems suited to insufflation and minimal port manipulation, whereas open repair techniques like Lichtenstein repair and mesh plug technique place a premium on handling characteristics, fixation options, and soft-tissue conformity. These clinical preferences drive design trade-offs for manufacturers balancing versatility against procedure-specific optimization.

Material type segmentation highlights the role of ePTFE composite and polypropylene composite constructs, each offered with or without anti-adhesive coating, and decisions between these options are influenced by surgeon experience, adhesion risk profiles, and institutional preferences for long-term tissue integration. Application-based segmentation-covering incisional hernia, inguinal hernia, and ventral hernia with further granularity into primary versus recurrent incisional and epigastric versus umbilical ventral types-reveals how clinical complexity and recurrence risk affect device selection and evidence requirements. Finally, sales channel segmentation differentiates direct sales from distributor networks, with distributor operations further divided into international and local distributors, and each channel imposes different service expectations, contracting structures, and regional market access dynamics. Together, these layered segments inform targeted development, go-to-market planning, and post-sale support models.

Detailed regional analysis emphasizing regulatory diversity, reimbursement complexity, and tailored commercialization approaches across global healthcare markets

Regional dynamics exert a powerful influence on adoption pathways, regulatory navigation, and commercial execution for composite hernia patches, and an effective strategy must align product design and go-to-market tactics with regional realities. In the Americas, healthcare systems vary widely between public and private payers, and there is significant concentration of advanced surgical adoption in high-volume centers, which prioritizes evidence generation and surgeon education programs to support minimally invasive approaches. Reimbursement frameworks and hospital procurement committees in this region favor demonstrable reductions in complications and readmissions.

Across Europe, the Middle East & Africa, regulatory conformity and reimbursement heterogeneity create a mosaic of opportunities and barriers; centralized approvals coexist with country-level coverage decisions, and pricing pressures in many markets require compelling health-economic narratives. In contrast, the Middle East and parts of Africa present pockets of rapid infrastructure investment where suppliers can partner with local providers to introduce advanced procedural training and supply-chain solutions. Transitioning eastward, the Asia-Pacific region demonstrates wide divergence between mature markets with advanced hospital systems and emerging markets with growing surgical capacity; local manufacturing and strategic distributor partnerships are often critical to scaling access, while culturally specific procurement practices and surgeon preferences influence adoption speed.

Taken together, regional insights underscore the importance of flexible commercial models, localized evidence initiatives, and investments in surgeon training and supply continuity to support sustained growth across diverse healthcare environments.

Strategic competitive landscape analysis showing how material innovation, evidence generation, and supply chain resilience drive differentiation and commercial advantage

Competitive dynamics among companies operating in the composite hernia patch space reflect varied strategic postures, with leaders differentiating through R&D investments, manufacturing footprint, and evidence generation. Firms focusing on material innovation pursue incremental improvements in coating technologies and polymer formulations, seeking to deliver clearer clinical advantages in adhesion prevention and tissue integration. Others emphasize systems-level solutions, bundling delivery devices, fixation adjuncts, and surgeon training to create value propositions that reduce operative time and complication risk.

Strategic partnerships, selective licensing, and targeted acquisitions have emerged as common tactics to accelerate time-to-market for novel materials and to secure distribution in key geographies. Moreover, companies that invest in post-market surveillance and registries strengthen customer trust by demonstrating long-term safety profiles, which becomes increasingly important as procurement committees demand outcomes-based evidence. Operational excellence in quality systems and supply chain redundancy is another differentiator, particularly for organizations that serve high-volume ambulatory centers where reliable delivery and consistent device performance are paramount.

Looking ahead, competitive advantage will accrue to companies that combine robust clinical data with scalable manufacturing, flexible commercialization channels, and programs that support surgeon adoption. Those who align product innovation with demonstrable procedural benefits and institutional cost priorities will be best positioned to influence purchasing decisions and clinical guidelines.

Practical, high-impact strategic actions for manufacturers and providers to accelerate clinical adoption, reduce supply chain exposure, and demonstrate procedural value

Industry leaders can pursue several pragmatic actions to strengthen market position, accelerate adoption, and manage risk across the composite hernia patch value chain. First, aligning product design with procedural workflows-specifically optimizing for laparoscopic delivery systems while maintaining versatility for open techniques-reduces friction for surgeons and broadens addressable use cases. By investing in surgeon training and proctoring, manufacturers can shorten learning curves and demonstrate consistent outcomes across care settings.

Second, diversifying supply chains and establishing regional manufacturing capabilities or preferred local partners mitigates tariff and logistics exposure while improving responsiveness to demand fluctuations. In parallel, investing in robust post-market data collection, registries, and real-world evidence projects supports reimbursement discussions and bolsters procurement negotiations; these initiatives should emphasize clinically relevant endpoints such as complication reduction and patient recovery metrics.

Third, companies should tailor commercial models by region and by provider type, integrating direct sales in high-touch accounts and selective distributor partnerships in markets where scale and local relationships are essential. Finally, adopting value-based contracting pilots with leading health systems can demonstrate total-cost-of-care improvements and build the business case for broader adoption. Taken together, these steps offer a cohesive roadmap for maintaining competitiveness and delivering measurable clinical and economic value.

Robust multi-method research design combining expert interviews, clinical literature synthesis, and supply chain analysis to validate findings and recommendations

The research underpinning this executive summary synthesized qualitative and quantitative inputs through a multi-method approach designed to ensure reliability, triangulation, and relevance to stakeholders. Primary research included structured interviews with a cross-section of stakeholders, encompassing surgeons experienced in laparoscopic and open techniques, hospital procurement leaders, distributor executives, and regulatory specialists. These conversations informed an understanding of procedural preferences, evidence expectations, and channel mechanics.

Secondary research involved a systematic review of peer-reviewed clinical literature, regulatory filings, and device labeling to characterize material properties, safety signals, and procedural outcomes. Data triangulation integrated supply chain intelligence and policy developments to assess impacts on sourcing and pricing dynamics. Throughout the process, findings were validated via expert panels and clinical advisors who reviewed key assumptions and identified potential blind spots.

Finally, methodological safeguards such as source corroboration, conflict-of-interest screening, and iterative revision cycles were employed to enhance objectivity. This rigorous approach supports confidence in the thematic conclusions and strategic recommendations presented here, while also enabling customization for client-specific scenarios and supplementary analyses where deeper granularity is required.

Synthesis of clinical, technological, and commercial imperatives underscoring strategic alignment between innovation, evidence, and operational execution for durable adoption

This executive summary distilled the interplay of clinical needs, material innovation, regulatory dynamics, and commercial forces that currently shape the composite hernia patch landscape. Key themes include the persistent shift toward minimally invasive care pathways, the emergence of advanced composite materials and coatings that reconcile integration with reduced adhesions, and the imperative for resilient supply chains in the face of policy-driven cost pressures. These converging trends influence product design, evidence-generation priorities, and go-to-market models for manufacturers and distributors alike.

Importantly, segmentation and regional analyses reveal that success requires tailored strategies: devices optimized for laparoscopic deployment excel in ambulatory settings, whereas hospitals place heavier weight on longitudinal outcomes and contracting flexibility. Competitive advantage accrues to organizations that pair compelling clinical evidence with operational reliability and localized commercialization tactics. In short, stakeholders that align innovation with procedural utility and institutional value imperatives will be best positioned to capture clinical adoption and secure durable partnerships across care settings.

This conclusion underscores the need for integrated planning across R&D, regulatory, and commercial functions to translate technical improvements into measurable clinical and economic benefits within diverse healthcare environments.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Composite Hernia Patch Market, by Material Type

• 8.1. ePTFE Composite
• 8.2. Polypropylene Composite

9. Composite Hernia Patch Market, by Approach

• 9.1. Laparoscopic Repair
  • 9.1.1. TAPP
  • 9.1.2. TEP
• 9.2. Open Repair

10. Composite Hernia Patch Market, by End User

• 10.1. Ambulatory Surgical Center
• 10.2. Hospital
  • 10.2.1. Private Hospital
  • 10.2.2. Public Hospital

11. Composite Hernia Patch Market, by Application

• 11.1. Incisional Hernia
  • 11.1.1. Primary Incisional
  • 11.1.2. Recurrent Incisional
• 11.2. Inguinal Hernia
• 11.3. Ventral Hernia
  • 11.3.1. Epigastric
  • 11.3.2. Umbilical

12. Composite Hernia Patch Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Composite Hernia Patch Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Composite Hernia Patch Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Composite Hernia Patch Market

16. China Composite Hernia Patch Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Aesculap AG
• 17.6. Atrium Medical Corporation
• 17.7. B. Braun Melsungen AG
• 17.8. Baxter International Inc.
• 17.9. Baxter International Inc.
• 17.10. Becton, Dickinson and Company
• 17.11. C. R. Bard, Inc.
• 17.12. Coloplast A/S
• 17.13. CONMED Corporation
• 17.14. Cook Medical Incorporated
• 17.15. Cousin Biotech
• 17.16. Dipromed SRL
• 17.17. FEG Textiltechnik mbH
• 17.18. Getinge AB
• 17.19. Integra LifeSciences Holdings Corporation
• 17.20. Johnson & Johnson
• 17.21. Lifecell Corporation
• 17.22. Lohmann & Rauscher GmbH & Co. KG
• 17.23. Medtronic plc
• 17.24. Smith & Nephew plc
• 17.25. Tela Bio, Inc.
• 17.26. Teleflex Incorporated
• 17.27. Tepha, Inc.
• 17.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL COMPOSITE HERNIA PATCH MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL COMPOSITE HERNIA PATCH MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPTFE COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPTFE COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPTFE COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY POLYPROPYLENE COMPOSITE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY POLYPROPYLENE COMPOSITE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY POLYPROPYLENE COMPOSITE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TAPP, BY REGION, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TAPP, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TAPP, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TEP, BY REGION, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TEP, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY TEP, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY OPEN REPAIR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY OPEN REPAIR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY OPEN REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY AMBULATORY SURGICAL CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIVATE HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIVATE HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIVATE HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PUBLIC HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PUBLIC HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PUBLIC HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIMARY INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIMARY INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY PRIMARY INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY RECURRENT INCISIONAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY RECURRENT INCISIONAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY RECURRENT INCISIONAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INGUINAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INGUINAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY INGUINAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, BY REGION, 2018-2032 (USD MILLION)
• TABLE 52. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 53. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 54. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 55. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPIGASTRIC, BY REGION, 2018-2032 (USD MILLION)
• TABLE 56. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPIGASTRIC, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 57. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY EPIGASTRIC, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 58. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY UMBILICAL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 59. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY UMBILICAL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 60. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY UMBILICAL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 61. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 62. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 63. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 64. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 65. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 66. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 67. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 68. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 69. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 70. AMERICAS COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 71. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 72. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 73. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 74. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 75. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 76. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 77. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 78. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 79. NORTH AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 80. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 81. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 82. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 83. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 84. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 85. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 86. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 87. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 88. LATIN AMERICA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 89. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 90. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 91. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 92. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 93. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 94. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 95. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 96. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 97. EUROPE, MIDDLE EAST & AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 98. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 99. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 100. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 101. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 102. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 103. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 104. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 105. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 106. EUROPE COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 107. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 108. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 109. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 110. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 111. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 112. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 113. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 114. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 115. MIDDLE EAST COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 116. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 117. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 118. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 119. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 120. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 121. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 122. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 123. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 124. AFRICA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 125. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 126. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 127. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 128. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 129. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 130. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 131. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 132. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 133. ASIA-PACIFIC COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 134. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 135. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 136. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 137. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 138. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 139. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 140. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 141. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 142. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 143. ASEAN COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 144. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 145. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 146. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 147. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 148. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 149. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 150. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 151. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 152. GCC COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 153. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 154. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 155. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 156. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 157. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 158. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 159. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 160. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 161. EUROPEAN UNION COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 162. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 163. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 164. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 165. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 166. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 167. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 168. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 169. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 170. BRICS COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 171. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 172. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 173. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 174. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 175. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 176. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 177. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 178. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 179. G7 COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 180. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 181. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 182. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 183. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 184. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 185. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 186. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 187. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 188. NATO COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 189. GLOBAL COMPOSITE HERNIA PATCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 190. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 191. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 192. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 193. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 194. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 195. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 196. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 197. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 198. UNITED STATES COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 199. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 200. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
• TABLE 201. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPROACH, 2018-2032 (USD MILLION)
• TABLE 202. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY LAPAROSCOPIC REPAIR, 2018-2032 (USD MILLION)
• TABLE 203. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 204. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
• TABLE 205. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 206. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY INCISIONAL HERNIA, 2018-2032 (USD MILLION)
• TABLE 207. CHINA COMPOSITE HERNIA PATCH MARKET SIZE, BY VENTRAL HERNIA, 2018-2032 (USD MILLION)